One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-133796
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
Affiliation: University of North Carolina at Chapel Hill, Columbia University Irving Medical Center, Sumitomo Dainippon Pharma (United States), Roswell Park Cancer Institute, University of Nebraska Medical Center, Ochsner Medical Center, Instituto de Investigación Sanitaria La Fe, Sidney Kimmel Comprehensive Cancer CenterZella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Acute Myeloid Leukemia (AML): Results of Newly Diagnosed High-Risk Exploratory Arm
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
